Industry: Machinery & Equipment
Published Date: 2026-04-19
Pages: 141 Pages
Report ld: 6507775
Request Sample
Customized Report
Automated Cryogenic Biobank Market Size(US$)

CAGR 2026-2032
10.3%
Market Size,2032
USD 8,028
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automated Cryogenic Biobank market was valued at US$ 4080 million in 2025 and is anticipated to reach US$ 8028 million by 2032, at a CAGR of 10.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Automated Cryogenic Biobank competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Offering comprehensive ultra-low temperature automated sample management systems for biological and compound samples
There is an ever-increasing demand for biological samples in fields such as medical research, the biomedical industry, and bioscience research. Automated cryogenic biobanks provide efficient storage and management solutions to meet the needs of large-scale, long-term and high-quality storage of biological samples.
This report delivers a comprehensive overview of the global Automated Cryogenic Biobank market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated Cryogenic Biobank. The Automated Cryogenic Biobank market size, estimates, and forecasts are provided in terms of output/shipments (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Automated Cryogenic Biobank market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Automated Cryogenic Biobank manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Automated Cryogenic Biobank manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Automated Cryogenic Biobank production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Automated Cryogenic Biobank consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Automated Cryogenic Biobank Market Overview
1.1 Product Definition
1.2 Automated Cryogenic Biobank by Type
1.2.1 Global Automated Cryogenic Biobank Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Minus 80 Celsius
1.2.3 Minus 196 Degrees Celsius
1.2.4 Other
1.3 Automated Cryogenic Biobank by Application
1.3.1 Global Automated Cryogenic Biobank Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Hospital
1.3.4 Commercial Storage Institutions
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Automated Cryogenic Biobank Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Automated Cryogenic Biobank Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Automated Cryogenic Biobank Production Estimates and Forecasts (2021–2032)
1.4.4 Global Automated Cryogenic Biobank Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Automated Cryogenic Biobank Production Market Share by Manufacturers (2021–2026)
2.2 Global Automated Cryogenic Biobank Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Automated Cryogenic Biobank, Industry Ranking, 2024 vs 2025
2.4 Global Automated Cryogenic Biobank Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Automated Cryogenic Biobank Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Automated Cryogenic Biobank, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Automated Cryogenic Biobank, Product Offerings and Applications
2.8 Global Key Manufacturers of Automated Cryogenic Biobank, Date of Entry into the Industry
2.9 Automated Cryogenic Biobank Market Competitive Situation and Trends
2.9.1 Automated Cryogenic Biobank Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Automated Cryogenic Biobank Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Automated Cryogenic Biobank Production by Region
3.1 Global Automated Cryogenic Biobank Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Automated Cryogenic Biobank Production Value by Region (2021–2032)
3.2.1 Global Automated Cryogenic Biobank Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Automated Cryogenic Biobank by Region (2027–2032)
3.3 Global Automated Cryogenic Biobank Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Automated Cryogenic Biobank Production Volume by Region (2021–2032)
3.4.1 Global Automated Cryogenic Biobank Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Automated Cryogenic Biobank by Region (2027–2032)
3.5 Global Automated Cryogenic Biobank Market Price Analysis by Region (2021–2032)
3.6 Global Automated Cryogenic Biobank Production, Value, and Year-over-Year Growth
3.6.1 North America Automated Cryogenic Biobank Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Automated Cryogenic Biobank Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Automated Cryogenic Biobank Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Automated Cryogenic Biobank Production Value Estimates and Forecasts (2021–2032)
4 Automated Cryogenic Biobank Consumption by Region
4.1 Global Automated Cryogenic Biobank Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Automated Cryogenic Biobank Consumption by Region (2021–2032)
4.2.1 Global Automated Cryogenic Biobank Consumption by Region (2021–2026)
4.2.2 Global Automated Cryogenic Biobank Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Automated Cryogenic Biobank Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Automated Cryogenic Biobank Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Automated Cryogenic Biobank Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Automated Cryogenic Biobank Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Automated Cryogenic Biobank Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Automated Cryogenic Biobank Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Automated Cryogenic Biobank Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Automated Cryogenic Biobank Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Automated Cryogenic Biobank Production by Type (2021–2032)
5.1.1 Global Automated Cryogenic Biobank Production by Type (2021–2026)
5.1.2 Global Automated Cryogenic Biobank Production by Type (2027–2032)
5.1.3 Global Automated Cryogenic Biobank Production Market Share by Type (2021–2032)
5.2 Global Automated Cryogenic Biobank Production Value by Type (2021–2032)
5.2.1 Global Automated Cryogenic Biobank Production Value by Type (2021–2026)
5.2.2 Global Automated Cryogenic Biobank Production Value by Type (2027–2032)
5.2.3 Global Automated Cryogenic Biobank Production Value Market Share by Type (2021–2032)
5.3 Global Automated Cryogenic Biobank Price by Type (2021–2032)
6 Segment by Application
6.1 Global Automated Cryogenic Biobank Production by Application (2021–2032)
6.1.1 Global Automated Cryogenic Biobank Production by Application (2021–2026)
6.1.2 Global Automated Cryogenic Biobank Production by Application (2027–2032)
6.1.3 Global Automated Cryogenic Biobank Production Market Share by Application (2021–2032)
6.2 Global Automated Cryogenic Biobank Production Value by Application (2021–2032)
6.2.1 Global Automated Cryogenic Biobank Production Value by Application (2021–2026)
6.2.2 Global Automated Cryogenic Biobank Production Value by Application (2027–2032)
6.2.3 Global Automated Cryogenic Biobank Production Value Market Share by Application (2021–2032)
6.3 Global Automated Cryogenic Biobank Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Haier
7.1.1 Haier Automated Cryogenic Biobank Company Information
7.1.2 Haier Automated Cryogenic Biobank Product Portfolio
7.1.3 Haier Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Haier Main Business and Markets Served
7.1.5 Haier Recent Developments/Updates
7.2 MGI
7.2.1 MGI Automated Cryogenic Biobank Company Information
7.2.2 MGI Automated Cryogenic Biobank Product Portfolio
7.2.3 MGI Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 MGI Main Business and Markets Served
7.2.5 MGI Recent Developments/Updates
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Automated Cryogenic Biobank Company Information
7.3.2 Thermo Fisher Scientific Automated Cryogenic Biobank Product Portfolio
7.3.3 Thermo Fisher Scientific Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Thermo Fisher Scientific Main Business and Markets Served
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.4 Origin Cell
7.4.1 Origin Cell Automated Cryogenic Biobank Company Information
7.4.2 Origin Cell Automated Cryogenic Biobank Product Portfolio
7.4.3 Origin Cell Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Origin Cell Main Business and Markets Served
7.4.5 Origin Cell Recent Developments/Updates
7.5 Askion Biobanking
7.5.1 Askion Biobanking Automated Cryogenic Biobank Company Information
7.5.2 Askion Biobanking Automated Cryogenic Biobank Product Portfolio
7.5.3 Askion Biobanking Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Askion Biobanking Main Business and Markets Served
7.5.5 Askion Biobanking Recent Developments/Updates
7.6 Labplan
7.6.1 Labplan Automated Cryogenic Biobank Company Information
7.6.2 Labplan Automated Cryogenic Biobank Product Portfolio
7.6.3 Labplan Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Labplan Main Business and Markets Served
7.6.5 Labplan Recent Developments/Updates
7.7 Liconic
7.7.1 Liconic Automated Cryogenic Biobank Company Information
7.7.2 Liconic Automated Cryogenic Biobank Product Portfolio
7.7.3 Liconic Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Liconic Main Business and Markets Served
7.7.5 Liconic Recent Developments/Updates
7.8 Irelec Alcen
7.8.1 Irelec Alcen Automated Cryogenic Biobank Company Information
7.8.2 Irelec Alcen Automated Cryogenic Biobank Product Portfolio
7.8.3 Irelec Alcen Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Irelec Alcen Main Business and Markets Served
7.8.5 Irelec Alcen Recent Developments/Updates
7.9 Hamilton
7.9.1 Hamilton Automated Cryogenic Biobank Company Information
7.9.2 Hamilton Automated Cryogenic Biobank Product Portfolio
7.9.3 Hamilton Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Hamilton Main Business and Markets Served
7.9.5 Hamilton Recent Developments/Updates
7.10 Panasonic Corporation
7.10.1 Panasonic Corporation Automated Cryogenic Biobank Company Information
7.10.2 Panasonic Corporation Automated Cryogenic Biobank Product Portfolio
7.10.3 Panasonic Corporation Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Panasonic Corporation Main Business and Markets Served
7.10.5 Panasonic Corporation Recent Developments/Updates
7.11 VWR
7.11.1 VWR Automated Cryogenic Biobank Company Information
7.11.2 VWR Automated Cryogenic Biobank Product Portfolio
7.11.3 VWR Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 VWR Main Business and Markets Served
7.11.5 VWR Recent Developments/Updates
7.12 Corning
7.12.1 Corning Automated Cryogenic Biobank Company Information
7.12.2 Corning Automated Cryogenic Biobank Product Portfolio
7.12.3 Corning Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Corning Main Business and Markets Served
7.12.5 Corning Recent Developments/Updates
7.13 Brooks Life Science
7.13.1 Brooks Life Science Automated Cryogenic Biobank Company Information
7.13.2 Brooks Life Science Automated Cryogenic Biobank Product Portfolio
7.13.3 Brooks Life Science Automated Cryogenic Biobank Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Brooks Life Science Main Business and Markets Served
7.13.5 Brooks Life Science Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Automated Cryogenic Biobank Industry Chain Analysis
8.2 Automated Cryogenic Biobank Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Automated Cryogenic Biobank Production Modes and Processes
8.4 Automated Cryogenic Biobank Sales and Marketing
8.4.1 Automated Cryogenic Biobank Sales Channels
8.4.2 Automated Cryogenic Biobank Distributors
8.5 Automated Cryogenic Biobank Customer Analysis
9 Automated Cryogenic Biobank Market Dynamics
9.1 Automated Cryogenic Biobank Industry Trends
9.2 Automated Cryogenic Biobank Market Drivers
9.3 Automated Cryogenic Biobank Market Challenges
9.4 Automated Cryogenic Biobank Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Automated Cryogenic Biobank was estimated to be worth US$ 4080 million in 2025 and is projected to reach US$ 8028 million, growing at a CAGR of 10.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
The global Automated Cryogenic Biobank market is projected to grow from US$ 3734 million in 2024 to US$ 7347 million by 2031, at a CAGR of 10.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 158
USD 4900.00
(Single User License)
The global Automated Cryogenic Biobank market size was US$ 3734 million in 2024 and is forecast to a readjusted size of US$ 7347 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 99
USD 4250.00
(Single User License)
The global market for Automated Cryogenic Biobank was estimated to be worth US$ 3734 million in 2024 and is forecast to a readjusted size of US$ 7347 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.
Published Date: 2025-01-26
Pages: 126
USD 3950.00
(Single User License)
The global market for Automated Cryogenic Biobank was valued at US$ 3734 million in the year 2024 and is projected to reach a revised size of US$ 7347 million by 2031, growing at a CAGR of 10.3% during the forecast period.
Published Date: 2025-01-26
Pages: 103
USD 2900.00
(Single User License)
Offering comprehensive ultra-low temperature automated sample management systems for biological and compound samples
Published Date: 2024-04-12
Pages: 111
USD 4900.00
(Single User License)
Offering comprehensive ultra-low temperature automated sample management systems for biological and compound samples
Published Date: 2024-02-08
Pages: 97
USD 2900.00
(Single User License)
The global market for Automated Cryogenic Biobank was estimated to be worth US$ 4080 million in 2025 and is projected to reach US$ 8028 million, growing at a CAGR of 10.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 145
The global Automated Cryogenic Biobank market is projected to grow from US$ 3734 million in 2024 to US$ 7347 million by 2031, at a CAGR of 10.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 158
The global Automated Cryogenic Biobank market size was US$ 3734 million in 2024 and is forecast to a readjusted size of US$ 7347 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 99
The global market for Automated Cryogenic Biobank was estimated to be worth US$ 3734 million in 2024 and is forecast to a readjusted size of US$ 7347 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.
Published: 2025-01-26
Pages: 126
The global market for Automated Cryogenic Biobank was valued at US$ 3734 million in the year 2024 and is projected to reach a revised size of US$ 7347 million by 2031, growing at a CAGR of 10.3% during the forecast period.
Published: 2025-01-26
Pages: 103
Offering comprehensive ultra-low temperature automated sample management systems for biological and compound samples
Published: 2024-04-12
Pages: 111
Offering comprehensive ultra-low temperature automated sample management systems for biological and compound samples
Published: 2024-02-08
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now